Overall, the GREAT algorithm revealed that tumor-specific H3K4me3 peaks were enriched for oncogenic signaling including p53, EGFR, differentiation and cell adhesion pathways, whereas normal-specific H3K4me3 showed immune response pathway signatures (Supplementary Figure 4b). This evidence concerns the gene TP53 and neoplasm.